Benzoic acid, 4-[[4-[[2-[2,4-dioxo-5-(phenylmethylene)-3-thiazolidinyl]acetyl]amino]benzoyl]amino]-, ethyl ester

Benzoic acid, 4-[[4-[[2-[2,4-dioxo-5-(phenylmethylene)-3-thiazolidinyl]acetyl]amino]benzoyl]amino]-, ethyl ester Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +17819995354
Email: marketing@targetmol.com
Products Intro: Product Name:VEGFR-2-IN-24
CAS:2455414-26-1
Package:100mg;2500USD|25mg;1520USD|50mg;1980USD
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Products Intro: Product Name:VEGFR-2-IN-24
CAS:2455414-26-1
Package:100mg/RMB 17500;25mg/RMB 10600;50mg/RMB 13800

Benzoic acid, 4-[[4-[[2-[2,4-dioxo-5-(phenylmethylene)-3-thiazolidinyl]acetyl]amino]benzoyl]amino]-, ethyl ester manufacturers

  • VEGFR-2-IN-24
  • VEGFR-2-IN-24 pictures
  • $2500.00
  • 2026-07-27
  • CAS:2455414-26-1
  • Purity:
  • Supply Ability: 10g
Benzoic acid, 4-[[4-[[2-[2,4-dioxo-5-(phenylmethylene)-3-thiazolidinyl]acetyl]amino]benzoyl]amino]-, ethyl ester Basic information
Product Name:Benzoic acid, 4-[[4-[[2-[2,4-dioxo-5-(phenylmethylene)-3-thiazolidinyl]acetyl]amino]benzoyl]amino]-, ethyl ester
Synonyms:Benzoic acid, 4-[[4-[[2-[2,4-dioxo-5-(phenylmethylene)-3-thiazolidinyl]acetyl]amino]benzoyl]amino]-, ethyl ester;VEGFR-2-IN-24
CAS:2455414-26-1
MF:C28H23N3O6S
MW:529.56
EINECS:
Product Categories:
Mol File:2455414-26-1.mol
Benzoic acid, 4-[[4-[[2-[2,4-dioxo-5-(phenylmethylene)-3-thiazolidinyl]acetyl]amino]benzoyl]amino]-, ethyl ester Structure
Benzoic acid, 4-[[4-[[2-[2,4-dioxo-5-(phenylmethylene)-3-thiazolidinyl]acetyl]amino]benzoyl]amino]-, ethyl ester Chemical Properties
density 1.424±0.06 g/cm3(Predicted)
pka12.80±0.70(Predicted)
Safety Information
MSDS Information
Benzoic acid, 4-[[4-[[2-[2,4-dioxo-5-(phenylmethylene)-3-thiazolidinyl]acetyl]amino]benzoyl]amino]-, ethyl ester Usage And Synthesis
UsesVEGFR-2-IN-24 is a potent VEGFR-2 inhibitor with IC50 value of 0.22 μM. VEGFR-2-IN-24 can be used for tumor research[1].
IC 50VEGFR2: 0.22 μM (IC50)
References[1] El-Adl K, et al. Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2,4-dione derivatives targeting VEGFR-2 enzyme. Bioorg Chem. 2020 Sep;102:104059. DOI:10.1016/j.bioorg.2020.104059
Benzoic acid, 4-[[4-[[2-[2,4-dioxo-5-(phenylmethylene)-3-thiazolidinyl]acetyl]amino]benzoyl]amino]-, ethyl ester Preparation Products And Raw materials
Tag:Benzoic acid, 4-[[4-[[2-[2,4-dioxo-5-(phenylmethylene)-3-thiazolidinyl]acetyl]amino]benzoyl]amino]-, ethyl ester(2455414-26-1) Related Product Information
Quinazoline, 4-[(4-bromophenyl)methoxy]- 1H-1,2,4-Triazole-3-carboxamide, 1-(3-chloro-4-fluorophenyl)-N-(3,4-dimethoxyphenyl)-5-(3,4,5-trimethoxyphenyl)- VEGFR3/FLT4 Protein, Human, Recombinant (His & Avi) 3-nitro-N-(8-quinolinyl)benzamide 2-Quinazolinecarboxylic acid, 4-[3-fluoro-4-[[[(3-methylphenyl)amino]carbonyl]amino]phenoxy]-, ethyl ester Pazopanib Impurity 3 VEGFR3/FLT4 Protein, Human, Recombinant (aa 25-776, His & Avi), Biotinylated 3-Pyridinecarbonitrile, 2-hydrazinyl-6-(2-naphthalenyl)-4-(4-nitrophenyl)- 2,4-PyriMidinediaMine with linker